SHC1
SHC-transforming protein 1
Also known as: p66, SHC, SHC1_HUMAN, ShcA
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P29353
- Gene
- SHC1
- Ensembl
- ENSG00000160691
- Chromosome
- 1
- Canonical length
- 583 aa
- Protein class
- Predicted intracellular proteins, RAS pathway related proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene encodes three main isoforms that differ in activities and subcellular location. While all three are adapter proteins in signal transduction pathways, the longest (p66Shc) may be involved in regulating life span and the effects of reactive oxygen species. The other two isoforms, p52Shc and p46Shc, link activated receptor tyrosine kinases to the Ras pathway by recruitment of the GRB2/SOS complex. p66Shc is not involved in Ras activation. Unlike the other two isoforms, p46Shc is targeted to the mitochondrial matrix. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2011]
Canonical amino-acid sequenceUniProt
583 residues, UniProt reviewed canonical sequence.
>P29353|SHC1
1 MDLLPPKPKY NPLRNESLSS LEEGASGSTP PEELPSPSAS SLGPILPPLP GDDSPTTLCS
61 FFPRMSNLRL ANPAGGRPGS KGEPGRAADD GEGIVGAAMP DSGPLPLLQD MNKLSGGGGR
121 RTRVEGGQLG GEEWTRHGSF VNKPTRGWLH PNDKVMGPGV SYLVRYMGCV EVLQSMRALD
181 FNTRTQVTRE AISLVCEAVP GAKGATRRRK PCSRPLSSIL GRSNLKFAGM PITLTVSTSS
241 LNLMAADCKQ IIANHHMQSI SFASGGDPDT AEYVAYVAKD PVNQRACHIL ECPEGLAQDV
301 ISTIGQAFEL RFKQYLRNPP KLVTPHDRMA GFDGSAWDEE EEEPPDHQYY NDFPGKEPPL
361 GGVVDMRLRE GAAPGAARPT APNAQTPSHL GATLPVGQPV GGDPEVRKQM PPPPPCPGRE
421 LFDDPSYVNV QNLDKARQAV GGAGPPNPAI NGSAPRDLFD MKPFEDALRV PPPPQSVSMA
481 EQLRGEPWFH GKLSRREAEA LLQLNGDFLV RESTTTPGQY VLTGLQSGQP KHLLLVDPEG
541 VVRTKDHRFE SVSHLISYHM DNHLPIISAG SELCLQQPVE RKLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SHC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.51
- Highest tissue expression
- 138 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 138 nTPM
- breast: 123 nTPM
- pituitary gland: 113 nTPM
- blood vessel: 104 nTPM
- smooth muscle: 100 nTPM
- lung: 100 nTPM
Single-cell type
- epicardial cells: 21 nCPM
- lymphatic endothelial cells: 20 nCPM
- enterocytes: 19 nCPM
- adipocytes: 18 nCPM
- salivary myoepithelial cells: 12 nCPM
- medullary thymic epithelial cells: 9.6 nCPM
Immune cell
- eosinophil: 58 nTPM
- non-classical monocyte: 48 nTPM
- intermediate monocyte: 48 nTPM
- total PBMC: 39 nTPM
- gdT-cell: 39 nTPM
- MAIT T-cell: 39 nTPM
Brain region
- thalamus: 63 nTPM
- pons: 56 nTPM
- medulla oblongata: 55 nTPM
- cerebral cortex: 54 nTPM
- hypothalamus: 48 nTPM
- spinal cord: 48 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.65
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.33
- DepMap mean gene effect
- -0.26
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin cytoskeleton organization
- angiogenesis
- cell-cell adhesion
- cellular response to growth factor stimulus
- defense response to bacterium
- epidermal growth factor receptor signaling pathway
- heart development
- insulin receptor signaling pathway
- insulin-like growth factor receptor signaling pathway
- intracellular signal transduction
- negative regulation of angiogenesis
- negative regulation of apoptotic process
- negative regulation of DNA-templated transcription
- positive regulation of cell population proliferation
- positive regulation of cell proliferation in bone marrow
- positive regulation of DNA-templated transcription
- positive regulation of MAPK cascade
- regulation of superoxide metabolic process
Molecular functions
- ephrin receptor binding
- epidermal growth factor binding
- epidermal growth factor receptor binding
- insulin receptor binding
- insulin-like growth factor receptor binding
- neurotrophin TRKA receptor binding
- phospholipid binding
- phosphotyrosine residue binding
- receptor tyrosine kinase binding
- transmembrane receptor protein tyrosine kinase adaptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SHC1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SHC1 as an antibody target. Whether an autoantibody or antibody against SHC1 could matter depends on whether native SHC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SHC1 is annotated at the cell surface, where native SHC1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SHC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...